Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000461127 | SCV000542105 | likely benign | Neurofibromatosis, type 1 | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002318508 | SCV000666678 | uncertain significance | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2022-03-22 | criteria provided, single submitter | clinical testing | The c.2689C>T (p.R897W) alteration is located in exon 21 (coding exon 21) of the NF1 gene. This alteration results from a C to T substitution at nucleotide position 2689, causing the arginine (R) at amino acid position 897 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Genome- |
RCV000461127 | SCV002562086 | uncertain significance | Neurofibromatosis, type 1 | 2022-03-15 | criteria provided, single submitter | clinical testing |